The invention relates to novel piperazine compounds of formula (I):
to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.
本发明涉及一种新的
哌嗪化合物,其
化学式为(I):以及它们的制备方法;含有该化合物的药物组合物;以及将该化合物用于治疗阻断Cav2.2
钙通道对于治疗疼痛等疾病是有益的治疗中。